Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Virax Biolabs Group Limited - Ordinary Shares (NQ:VRAX)

0.2106 +0.0076 (+3.74%)
Streaming Delayed Price Updated: 1:45 PM EST, Mar 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Virax Biolabs Group Limited - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Monkeypox Stocks GOVX, VRAX, SIGA Rocket on Vaccine Shortage Fears ↗
Monkeypox stocks are rallying today amid worries about a shortage of vaccines for the illness in the United States. 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
Good morning, trader! We're starting off Monday with a breakdown of the biggest pre-market stock movers traders will want to watch! 
Via InvestorPlace
News headline image
Why Celyad Oncology Is Trading Higher By Over 31%; Here Are 29 Stocks Moving Premarket ↗
Gainers MAIA Biotechnology, Inc. (NASDAQ: MAIA) rose 37.9% to $8.00 in pre-market trading after jumping 30% on Friday. The company agreed to initially offer 2.00 million shares to the public at a $5.00... 
Via Benzinga
News headline image
This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday ↗
Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings... 
Via Benzinga
News headline image
Why Meta Platforms Is Trading Lower By More Than 6%: Here Are 34 Stocks Moving Premarket ↗
Gainers JAKKS Pacific, Inc. (NASDAQ: JAKK) rose 34.7% to $23.01 in pre-market trading after the company reported better-than-expected Q2 results. 
Via Benzinga
News headline image
Why Is Ayala Pharmaceuticals Trading Higher By Around 130%? 45 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) jumped 130% to $2.0001 after the company filed a request for the withdrawal of the Registration Statement on Form S-1. 
Via Benzinga
News headline image
Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday ↗
Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1. 
Via Benzinga
News headline image
Dow Drops Over 100 Points; Coca-Cola Tops Q2 Views ↗
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Tuesday. 
Via Benzinga
News headline image
Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit
Kits Available in July for Distribution 
From Virax Biolabs Group Limited
Via GlobeNewswire
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
Good morning! We're starting off Tuesday with an overview of the biggest pre-market stock movers traders will want to know about! 
Via InvestorPlace
News headline image
Why Walmart is Trading Higher By More Than 9%: Here Are 25 Stocks Moving Premarket ↗
Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) rose 64.4% to $1.43 in pre-market trading. Ayala Pharmaceuticals filed request for withdrawal of registration statement on form S-1. 
Via Benzinga
News headline image
Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday ↗
Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 150.4% to close at $1.59 on Monday after declining 8% on Friday. 
Via Benzinga
News headline image
Opening Day: Virax Biolabs Shares Soar In Trading Debut ↗
Shares of Virax, the U.K.-based provider of diagnostic tests and PPE, including test kits for COVID-19, as much as quadrupled in value in their debut session following the company's IPO. Virax Biolabs... 
Via Talk Markets
News headline image
Virax Biolabs Group Limited Stock Down 9.00% Since IPO ↗
Virax Biolabs Group Limited (NASDAQ:VRAX) opened up its shares for public trading for the first time since it filed for IPO in March 2022. The company agreed to initially offer 1.35 million shares to... 
Via Benzinga
News headline image
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday ↗
Gainers 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  During Friday's session, 61 companies made new 52-week lows. 
Via Benzinga
News headline image
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday ↗
 Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period... 
Via Benzinga
News headline image
Nasdaq Jumps Over 100 Points; U.S. Jobless Claims Rise To This Level ↗
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Thursday. 
Via Benzinga
News headline image
Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending... 
Via Benzinga
News headline image
U.S. President Joe Biden Tests Positive For COVID-19; Tabula Rasa HealthCare Shares Spike Higher ↗
U.S. stocks traded mixed midway through trading, with the Dow Jones dropping around 100 points on Thursday. 
Via Benzinga
News headline image
Why U.S. Stocks Are Trading Mixed; ECB Boosts Rates For First Time In 11 Years ↗
U.S. stocks traded mixed this morning, with the Dow Jones dropping around 100 points on Thursday. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.